ADC Therapeutics (ADCT) Change in Inventory (2023 - 2026)

ADC Therapeutics has disclosed Change in Inventory across 4 years of filings, most recently posting -$16000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at -$16000.0, down 105.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 40.59% YoY), and the FY2025 annual result was $2.4 million, down 36.13% from the prior year.
• Change in Inventory came in at -$16000.0 for Q1 2026 at ADC Therapeutics, down from $853000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $3.5 million in Q3 2023 to a low of -$518000.0 in Q2 2024.
• The 4-year median for Change in Inventory is $568000.0 (2024), against an average of $908076.9.
• Peak annual rise in Change in Inventory reached 1775.45% in 2024, while the deepest fall reached 125.24% in 2024.
• ADC Therapeutics' Change in Inventory stood at -$167000.0 in 2023, then jumped by 1775.45% to $2.8 million in 2024, then sank by 69.51% to $853000.0 in 2025, then slumped by 101.88% to -$16000.0 in 2026.
• The last three Change in Inventory figures came in at -$16000.0 (Q1 2026), $853000.0 (Q4 2025), and $516000.0 (Q3 2025), per Business Quant data.